⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Orchid Pharma Ltd and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Orchid Pharma Ltd
↗Chennai, India
Orchid Pharma is a vertically integrated pharmaceutical company based in Chennai, India, with established capabilities in research, manufacturing, and marketing. The company specializes in Active Pharmaceutical Ingredients (APIs) and formulations, with a strong focus on cephalosporin antibiotics, anti-diabetics, and other chronic therapy segments.
Following a period of financial restructuring, the company was acquired by Dhanuka Laboratories in 2020. Orchid Pharma is recognized for its drug discovery efforts, notably the development of Enmetazobactam, a novel antibiotic approved in the U.S., Europe, and India.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Antibiotics, APIs, and Formulations
SIZE & FINANCIALS
Employees:1001-5000
Founded:1992
Ownership:public
Status:operating
STOCK
Exchange:NSE|BSE
Ticker:ORCHPHARMA
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:12
Trial Phases:-
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Parent Company:Dhanuka Laboratories
Acquired By:Dhanuka Laboratories (2020-03-01)
Key Partnerships:Allecra Therapeutics (Asset acquisition), Dhanuka Laboratories (Parent)
COMPETITION
Position:Challenger
Competitors:Aurobindo Pharma, Lupin, Sun Pharma
LEADERSHIP
Key Executives:
Manish Dhanuka - Managing Director
Ram Gopal Agarwal - Chairman
Scientific Founders:Kailasam Raghavendra Rao
LINKS
Website:orchidpharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Orchid Pharma Ltd. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.